The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Trimipramine
Trimipramine · TRIMIPRAMINE MALEATE 100 mg/1 · Capsule · Oral · Breckenridge Pharmaceutical, Inc.
NDC 51991-0946-01 · 100 CAPSULE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$5.58per unit
middle half $5.10–$7.01 · 5,496 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $5.58
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 4 · prior auth 15% · step therapy 0% · qty limit 26%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$622.84
Reported to Texas DSHS · 2026 annual filing · Breckenridge Pharmaceutical
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis
- api manufacture
- analysis
- PRC Ticinum Lab SrlItalyanalysis
- Redox SrlItalyanalysis
- Rivopharm SaSwitzerlandanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA208127
- TE code
- AB
- Approval date
- Apr 15, 2016
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Trimipramine (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Breckenridge Pharmaceutical, Inc. | TRIMIPRAMINE MALEATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Breckenridge Pharmaceutical, Inc. | TRIMIPRAMINE MALEATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Breckenridge Pharmaceutical, Inc. | TRIMIPRAMINE MALEATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Trimipramine — NDC 51991-0946-01," retrieved September 3, 2026, https://drugdashboards.com/drug/51991094601.
Free to cite with attribution — see how the data is put together.